Shenzhen Weiguang Biological Hits Day High with 7.41% Surge

Shenzhen Weiguang Biological Products Co., Ltd. has experienced a significant uptick in its stock performance, gaining 7.41% on August 26, 2026. The stock reached an intraday high of CNY 24.81, marking a notable achievement in a day where the broader China Shanghai Composite index only rose by 0.59%. Over the past week, Shenzhen Weiguang has shown impressive momentum with a 21.71% increase, and its one-month performance stands at 28.83%, significantly outpacing the Shanghai Composite's 2.58% gain during the same period. However, the company has faced challenges over the longer term, with a one-year performance decline of 17.81% and a three-year drop of 26.61%, indicating consistent underperformance against the benchmark. Despite these long-term hurdles, the recent surge in stock price reflects a moment of positive activity for Shenzhen Weiguang, which operates within the pharmaceuticals and biotechnology sector. The company has a market capitalization of CNY 4,665 million and maintains a price-to-earnings ratio of 20.00, alongside a dividend yield of 0.97%.